XML 64 R39.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Income (Loss) Before Income Taxes
Domestic and foreign components of the Company’s income (loss) before income taxes were as follows:

SuccessorPredecessor
Period from January 27, 2022 through December 31, 2022Period from January 1, 2022 through January 26, 2022Year Ended December 31, 2021
Domestic
$(480,672)$(38,068)$30,521 
Foreign
(63,383)378 3,440 
Income (loss) before income taxes
$(544,055)$(37,690)$33,961 
Schedule of Income Tax Provision (Benefit)
The components of the income tax provision (benefit) were as follows:

SuccessorPredecessor
Period from January 27, 2022 through December 31, 2022Period from January 1, 2022 through January 26, 2022Year Ended December 31, 2021
Current:


Federal$79 $— $— 
State426 17 55 
Foreign
5,317 170 1,882 
Total current provision
$5,822 $187 $1,937 
Deferred:
Federal$(89,997)$— $— 
State(8,769)— — 
Foreign
(9,032)(816)(972)
Total deferred (benefit)
$(107,798)$(816)$(972)
Income tax (benefit) provision
$(101,976)$(629)$965 
Schedule of Effective Income Tax Rate
A reconciliation of the statutory tax rate to the effective income tax rate for the periods presented was as follows:


SuccessorPredecessor
Period from January 27, 2022 through December 31, 2022Period from January 1, 2022 through January 26, 2022Year Ended December 31, 2021
Amount%Amount%Amount%
Income tax (benefit) provision at statutory tax rate$(114,252)21.0 %$(7,915)21.0%$7,132 21.0%
State tax, net of federal(5,470)1.015 55 0.2
Non-Controlling interests19,205 (3.5)— — 
Effect of flow-through entity— 7,994 (21.2)(6,409)(18.9)
Changes in unrecognized tax benefits8,940 (1.6)— — 
Foreign income taxes at different statutory rate1,152 (0.2)18 88 0.3
Investment in partnership basis adjustments(13,491)2.4— — 
Other1,940 (0.4)(741)1.999 0.2
Effective income tax rate$(101,976)18.7%$(629)1.7%$965 2.8%
Schedule of Unrecognized Tax Benefits
The aggregate amount of gross unrecognized tax benefits related to uncertain tax positions were as follows:

Gross Unrecognized Tax Benefits
January 1, 2021 (Predecessor)$— 
Increases based on tax positions related to prior periods— 
Increases based on tax positions related to current periods— 
December 31, 2021 (Predecessor)$— 

Gross Unrecognized Tax Benefits
January 1, 2022 (Predecessor)$— 
Increases based on tax positions related to prior periods— 
Increases based on tax positions related to current periods— 
January 26, 2022 (Predecessor)$— 

Gross Unrecognized Tax Benefits
January 27, 2022 (Successor)$— 
Increases based on tax positions related to prior periods221 
Increases based on tax positions related to current periods11,061 
December 31, 2022 (Successor)$11,282 
Schedule of Tax Years that Remain Subject to Examination in Major Tax Jurisdictions
The earliest tax years that remain subject to examination in the major tax jurisdictions in which the Company operates were as follows:

JurisdictionTax Year
United States2019
California2018
United Kingdom2021
Netherlands2016
Schedule of Deferred Income Taxes The components of the deferred income taxes were as follows:
SuccessorPredecessor
December 31, 2022December 31, 2021
Deferred tax assets:
Net operating losses$16,053 $— 
Interest expense1,196 165 
Other1,920 
Total deferred tax assets
19,169 170 
Valuation allowance(1,087)(170)
Total net deferred tax assets$18,082 $— 
Deferred tax liabilities:
Investment in partnerships$21,144 $— 
Intangibles40,112 7,789 
Other171 — 
Total deferred tax liabilities
$61,427 $7,789 
Net deferred tax liabilities
$43,345 $7,789 
Schedule of Valuation Allowance The change in the valuation allowance was comprised of the following:
Valuation Allowance
January 1, 2021 (Predecessor)$170 
Increases in valuation allowance recorded through earnings— 
December 31, 2021 (Predecessor)$170 

Valuation Allowance
January 1, 2022 (Predecessor)$170 
Increases in valuation allowance recorded through earnings— 
January 26, 2022 (Predecessor)$170 

Valuation Allowance
January 27, 2022 (Successor)$170 
Increases in valuation allowance recorded through earnings917 
December 31, 2022 (Successor)$1,087